000			01690 a2200493 4500
005			20250516155827.0
264		0	_c20140220
008			201402s 0 0 eng d
022			_a1769-6690
024	7		_a10.1016/j.medmal.2013.05.003 _2doi
040			_aNLM _beng _cNLM
100	1		_aHonnorat, E
245	0	0	_aEncephalitis due to Mycobacterium tuberculosis in France. _h[electronic resource]
260			_bMedecine et maladies infectieuses _cJun 2013
300			_a230-8 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAntitubercular Agents _xtherapeutic use
650	0	4	_aBlood Glucose _xanalysis
650	0	4	_aBrain _xpathology
650	0	4	_aBrain Damage, Chronic _xepidemiology
650	0	4	_aCerebrospinal Fluid Proteins _xanalysis
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEncephalitis _xdiagnosis
650	0	4	_aEncephalitis, Viral _xepidemiology
650	0	4	_aFemale
650	0	4	_aFrance _xepidemiology
650	0	4	_aGlucose _xcerebrospinal fluid
650	0	4	_aHospitalization _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeuroimaging
650	0	4	_aTreatment Outcome
650	0	4	_aTuberculosis, Central Nervous System _xdiagnosis
650	0	4	_aTuberculosis, Multidrug-Resistant _xepidemiology
650	0	4	_aYoung Adult
700	1		_aDe Broucker, T
700	1		_aMailles, A
700	1		_aStahl, J P
773	0		_tMedecine et maladies infectieuses _gvol. 43 _gno. 6 _gp. 230-8
856	4	0	_uhttps://doi.org/10.1016/j.medmal.2013.05.003 _zAvailable from publisher's website
999			_c22881554 _d22881554